One sentence summary: This study demonstrates the inhibitory effect of secondary bile acids including lithocholic acid and deoxycholic acid against Candida albicans growth and morphogenesis.
INTRODUCTION
Candida albicans, an opportunistic pathogen in the human gastrointestinal (GI) tract, causes life-threatening infections especially in immunocompromised individuals (Hajjeh et al. 2004; Wisplinghoff et al. 2004; Lockhart et al. 2012; Pfaller et al. 2012; Huffnagle and Noverr 2013) . Candida albicans is the fourth most common cause of systemic nosocomial infections, causing more than 40% mortality in infected humans (Wisplinghoff et al. 2004; Falagas, Apostolou and Pappas 2006; Chi et al. 2011) . Furthermore, a limited number of approved antifungal drugs in addition to the emergence of Candida strains resistant to current antifungal agents suggest that alternative, novel methods to prevent and treat C. albicans are in urgent need (Boken, Swindells and Rinaldi 1993) . Since the majority of systemic C. albicans infections stem from endogenous GI colonization and dissemination (Nucci and Anaissie 2001; Miranda et al. 2009 ), understanding the mechanisms associated with GI colonization is essential to develop novel approaches to prevent C. albicans colonization and pathogenesis.
Though more than 20% of humans are colonized with C. albicans in the GI tract (Standaert-Vitse et al. 2009; Fan et al. 2015) , adult mice are resistant to GI colonization of C. albicans. However, mice treated with antibiotics become susceptible to C. albicans infection (Conti et al. 2014 ); yet, the mechanisms associated with C. albicans GI colonization remain unclear. A recent study indicated that gut bacteria-namely Firmicutes and Bacteriodes-induce hypoxia-inducible factor-1α and antimicrobial peptide LL-37 and play an important role in C. albicans GI colonization resistance in mice (Fan et al. 2015) . However, antibiotic treatment not only alters the gut microbiota but also changes the composition of gut metabolome, especially secondary bile acids. Elegant studies by Theriot et al. have shown that the concentration and composition of secondary bile acids in the gut are significantly altered upon antibiotic treatment (Theriot et al. 2014; Theriot, Bowman and Young 2016) . They also demonstrated that secondary bile acids possess direct antimicrobial activity against Clostridium difficile and play a major role in maintaining GI colonization resistance against Cl. difficile (Theriot et al. 2014; Theriot, Bowman and Young 2016) . Based on these findings, we hypothesize that secondary bile acids might have direct antifungal activity against C. albicans and may play a critical role in maintaining GI colonization resistance against C. albicans.
To test if secondary bile acids possess antifungal activity against C. albicans, we used in vivo micelle concentrations of secondary bile acids present in the cecum and investigated their effect on C. albicans growth, germ tube, hyphae and biofilm formation, and their impact on C. albicans attachment to intestinal cells. Results from this study demonstrate that secondary bile acids possess direct antifungal activity on C. albicans, explaining a potential mechanism for GI colonization resistance against C. albicans.
MATERIALS AND METHODS

Strains and reagents
Candida albicans (Robin) Berkhout (ATCC 10231, VA) and human colon cancer cells (HCT116) (ATCC CCL-247, VA) were purchased from ATCC. Media used in this study include YPD Agar (BD Biosciences, CA), RPMI 1640 (Gibco-Thermo Fisher, MA), D-Glucose (Thermo Fisher, MA), MOPS (Sigma, MO), McCoy's 5A (ATCC, VA) and Fetal Bovine Serum (Atlanta Biologicals, GA). Lithocholic acid (LCA), deoxycholic acid (DCA), hyodeoxycholic acid (HDCA) and ursodeoxycholic acid (UDCA) were purchased from Sigma-Aldrich (MO). Other reagents were purchased as indicated: MTS (Promega, WI), PMS (Sigma, MO), crystal violet (Acros Organics-Thermo Fisher, MA), D-glucose (Thermo Fisher, MA), paraformaldehyde (Alfa Aesar, MA), ethanol (Millipore-SigmaAldrich, MO), rabbit polyclonal C. albicans antibody and goat antirabbit IgG secondary antibody (Invitrogen-Thermo Fisher, MA), Fluorsave (Millipore, MA).
Growth assay
Candida albicans was grown in RPMI 1640 buffered to pH 7.0 with 0.165M MOPS and supplemented with 2% D-glucose. Colonies were taken from freshly streaked C. albicans culture on YPD agar plates and added to 6-mL of PBS until the suspension matched the McFarland standard 0.5. The stock solution in PBS was then diluted by a 1:1700 ratio in the RPMI media yielding an inoculum size of 600-900 CFU/mL. Candida albicans treated with indicated bile acids was incubated at 30
• C and the growth was measured using spectrophotometer at the optical density of 600 nm at 24 and 48 h after incubation.
Germ tube and hyphal assays
Hyphae-inducing media composed of RMPI 1640 buffered to pH 7.0 with 0.165M MOPS and supplemented with 2% D-glucose and 30% fetal bovine serum (FBS) (Taschdjian, Burchall and Kozinn 1960; Braun and Johnson 1997; Nantel et al. 2002) . Forty small colonies from freshly streaked C. albicans culture on YPD agar plates were inoculated into 15 mL of hyphae-inducing media, yielding an inoculum size of 4 × 10 6 CFU/mL that was treated with LCA (0.01%), DCA (0.05%), DCA (0.05%) + LCA (0.01%) or ethanol (vehicle) in a 1-mL volume. Treatment groups were incubated for 90 min at 37
• C to promote hyphae formation (Taschdjian, Burchall and Kozinn 1960; Braun and Johnson 1997; Nantel et al. 2002) and the cells were washed with PBS and fixed with 4% paraformaldehyde. CFUs of each treatment group were determined to assess the viability after 90 min. Coverslips were mounted using 70% glycerol and images were taken using brightfield microscopy (NIS Elements-Nikon, NY). Germ tube formation was assessed using ×20 magnification by counting the number of cells with germ tube, with an n = 3 for each treatment group and a minimum cell count of 200 for each replicate. Germ tube length was measured using ×40 magnification and quantified using NIS-Elements software (Nikon, NY) with an n = 4 for each treatment group and a minimum measurement of four germ tubes per field. In addition, hyphal growth was assessed using a crystal violet assay as previously described (Abe et al. 1994) . Candida albicans was grown in hyphae-inducing medium in the presence or absence of secondary bile acids in 96-well plates and incubated for 12 h overnight at 37
• C. CFUs of each treatment group were determined to assess C. albicans growth. After incubation, medium was removed and plates were washed with 70% ethanol and sterile water. One hundred microliters of 0.02% crystal violet in PBS was then added to each well and incubated for 15 min. Plates were washed once with 0.25% SDS and twice with sterile water. Plates were then dried and 200 μL of crystal violet-extracting solution (150 μL isoproponal with 0.04N HCL + 50 μL 0.25% SDS) was added and mixed thoroughly. Absorbance was measured using a spectrophotometer at 590 nm and background was subtracted using 700 nm. Experiments were performed in triplicates with an n = 12 for each treatment group in each replicate. Percent hyphae in different groups was determined relative to the ethanol-treated control groups.
Determining metabolic activity in C. albicans biofilm and planktonic cells
Candida albicans (7 × 105-1 × 10 6 CFU/mL) grown in RMPI 1640 buffered to pH 7.0 with 0.165M MOPS and supplemented with 2% D-glucose was treated with indicated bile acids for 48 h at 37 • C (Chandra et al. 2001; Ramage et al. 2002; Nett et al. 2011 ).
CFUs of each treatment group were determined to assess the viability after 48 h of treatment After incubation, media containing plankotonic cells was removed from the plates and reseeded into a new 96-well plate. Original plates containing C. albicans biofilm were washed with PBS and treated with RPMI 1640 media (100 μL) containing MTS and PMS (20 μL) for 1 h according to manufacturer's directions. In addition, MTS/PMS was also added directly to the 96-well plates containing plankotonic cells and incubated for 2 h. Absorbance was measured at 490 nm, and the background was subtracted using 700 nm. Experiments were performed in triplicates with an n = 12 for each treatment group in each replicate. Percent metabolic activity in the biofilm and planktonic cells were determined relative to the ethanol-treated control groups.
Candida albicans attachment assay
HCT116 cells were seeded in 96-well plates or 6-well plates in McCoy's 5A medium with 10% FBS at a seeding density of 30 000 cells/well (96-well plate) or 500 000 cells/well (6-well plate) and were grown to 90% confluency. The 6-well plates contained 18 mm × 18 mm sterile square coverslips prior to cell seeding. Candida albicans (4 × 10 6 CFU/mL) was cultured in RMPI 1640 buffered to pH 7.0 with 0.165M MOPS and supplemented with 2% D-glucose and 30% FBS in a 1-mL volume. For the quantitative attachment assay, Candida cells were treated with indicated bile acids for 2 h at 37 • C. Cells were then centrifuged and RPMI media was removed and replaced with McCoy's 5A media. Candida albicans (20 μL) from treatment groups was then added to 96-well plate containing HCT116 cells. After incubating HCT116 cells with pre-treated C. albicans for 15 min, the wells were washed three times with PBS to remove unattached C. albicans and mammalian cells were then lysed with sterile water. Lysate was serially diluted (2-fold) in RPMI medium and plated onto YPD agar plates. After incubating the plates for 24 h at 30
CFUs were counted and the percentage of C. albicans attached to the mammalian cells was determined relative to the control groups.
Similarly for microscopic imaging, 200 μL of C. albicans pretreated with indicated bile acids was added to the 6-well plate containing HCT116 cells. After incubating for 15 min, McCoy's media containing C. albicans was aspirated and wells were washed three times with PBS and fixed with 4% paraformaldehyde. Wells were again washed three times with PBS and incubated with C. albicans primary antibody, followed by incubation with a rabbit polyclonal secondary antibody. Wells were then washed three times with PBS and coverslips inside the wells were removed and mounted onto slides using mounting media Images were taken using fluorescent microscopy (NIS Elements-Nikon, NY) at ×40 magnification.
Statistical analyses
Statistical analyses were performed using GraphPad Prism 6.0 (GraphPad Software, La Jolla, CA). P values were calculated via the Student t-test and P-values of (P * ≤ 0.05, P * * ≤ 0.01) were considered significant.
RESULTS
Secondary bile acids inhibit C. albicans growth
The effect of secondary bile acids including LCA, DCA, UDCA and HDCA on C. albicans growth was evaluated. LCA and DCA at the cecal micelle concentration (Theriot, Bowman and Young 2016) significantly inhibited the growth of C. albicans in a concentration-dependent manner. After 24 h of treatment, 0.002% LCA (20 μg/mL) inhibited more than 80% of the growth followed by 90% inhibition at concentrations of 0.006% (60 μg/mL) and 0.013% (130 μg/mL), respectively (Fig. 1A) . This trend continued into the 48-h mark, with LCA showing 30% inhibition at 0.003% (30 μg/mL) followed by 50% inhibition at 0.013% (130 μg/mL) (Fig. 1A) . Furthermore, DCA was effective at inhibiting C. albicans growth at 0.05% (500 μg/mL) and 0.1% (1000 μg/mL) concentrations (Fig. 1B) . DCA treatment (0.05%) significantly inhibited more than 60% of C. albicans growth at 24 h and 20% at 48 h (Fig. 1B) . Growth was entirely inhibited at 48 h with 0.1% (1000 μg/mL) DCA; however, the 24-h readout of 0.1% DCA was not determined due to solubility issues skewing the readout dramatically (Fig. 1B) . We also determined the minimum inhibitory concentration (MIC) of LCA and DCA against C. albicans. We found that MIC of LCA and DCA was 2000 and 1000 μg/mL after 24 h of incubation, respectively. HDCA and UDCA exhibited significant inhibition only at very high concentrations (ranging from 0.05% to 0.2% [500-2000 μg/mL]) at 48 h; however, solubility issues at these concentrations impede analysis at 24 h ( Fig. 1C and D) . Moreover, these concentrations were not correlated with in vivo cecal micelle concentrations (Theriot, Bowman and Young 2016) . Taken together, LCA and DCA significantly inhibited the growth of C. albicans at in vivo cecal micelle concentrations.
LCA and DCA inhibit C. albicans germ tube formation
To assess the effect of LCA and DCA on C. albicans germ tube formation, qualitative and quantitative microscopy analyses were performed. LCA or DCA alone was not effective at inhibiting germ tube formation; however, the combination of LCA and DCA significantly inhibited germ tube formation by more than 50% ( Fig. 2A and B) . We further explored the effect of LCA and DCA in attenuating the length of germ tube formation. Quantitative microscopic analyses of germ tubes revealed that the combination of LCA and DCA was effective at inhibiting the length of germ tubes after 90 min of incubation (Fig. 2C) . To rule out the effect of LCA and DCA on C. albicans growth in the presence of 30% FBS, CFU was determined in control and treatment groups. Results indicate that treatment with LCA or DCA in the presence of 30% FBS has no effect on C. albicans CFUs (Fig. 2D) . Collectively, LCA and DCA significantly inhibited the length and number of C. albicans germ tubes without considerably affecting the growth of C. albicans ( Fig. 2A-D) .
LCA and DCA inhibit C. albicans hyphae formation
The effect of LCA and DCA on C. albicans hyphae formation was evaluated using crystal violet and microscopic analysis. Ethanoltreated control group showed massive hyphal growth after 12 h; however, the presence of LCA and DCA significantly inhibited hyphal growth. LCA (0.01% [100 μg/mL]) and DCA (0.05% [500 μg/mL]) inhibited 30% and 90% of C. albicans hyphae formation, respectively (Fig. 3A) . However, the combination of 0.05% DCA and 0.01% LCA showed no improvement of inhibition compared to DCA treatment alone (Fig. 3A) . Microscopic observations of LCA-and DCA-treated C. albicans cells complement the findings from the crystal violet assay (Fig. 3B) . CFU analysis of treatment groups after incubation with LCA and/or DCA under hyphae-inducing media conditions concludes that growth arrest is not a factor in inhibiting hyphae formation (Fig. 3C) . Collectively, results from these experiments indicate that LCA and DCA reduced hyphae formation and inhibited yeast-to-hyphae transition without considerably affecting the growth of C. albicans.
LCA and DCA inhibit C. albicans biofilm formation
The effect of LCA and DCA on C. albicans biofilm formation was quantified using an MTS reduction assay and percent viabilities were calculated by expressing metabolic activities in relative to the ethanol-treated control groups. Biofilm-forming C. albicans (ATCC 10231) were grown in 96-well tissue culture-treated plates in the presence and absence of bile acids. After 48 h of Figure 1 . Secondary bile acids inhibit C. albicans growth. Candida albicans grown in the presence and absence of (A) LCA, (B) DCA, (C) HDCA and (D) UDCA at indicated concentrations and OD (600 nm) was measured using a spectrophotometer at 24 and 48 h. Percent growth was calculated relative to the ethanol-treated control groups. Experiments were repeated at least three times and representative data are shown here. Data are represented as means ± SEM. Statistical significance was evaluated using students t-test and P values ( * ≤ 0.05, * * ≤ 0.01) were considered as significant.
treatment, planktonic cells were removed and the metabolic activity was determined separately in attached biofilm and in planktonic cell suspension. All treatment groups significantly reduced the metabolic activity of C. albicans biofilms. LCA (0.01%), DCA (0.05%), and a combination of 0.01% LCA and 0.05% DCA significantly reduced the metabolic activity of C. albicans in biofilms by 24%, 33% and 65%, respectively (Fig. 4A) . Conversely, metabolic activity of planktonic cells in the bile acidtreated groups was significantly higher than the ethanol-treated control groups. LCA (0.01%), DCA (0.05%), and a combination of 0.01% LCA and 0.05% DCA treatment showed 32%, 53% and 92% increase in metabolic activity in the planktonic cell suspension obtained from the biofilm culture, respectively (Fig. 4B) . These results indicate that a larger proportion of C. albicans in the control group remain in the biofilm phase (noted by an increased metabolic activity in the control biofilm); however, in LCA and DCA-treated groups, biofilm formation was inhibited, thus resulting in a significantly higher proportion of planktonic cells (noted by an increased metabolic activity in treated planktonic cells) ( Fig. 4A and B) . Furthermore, CFU analysis of treatment groups after 48 h of treatment concludes that LCA and DCA did not affect the growth of C. albicans in the experimental biofilm condition and therefore growth arrest was not a contributing factor in biofilm inhibition (Fig. 4C) . These results show that LCA and DCA significantly inhibit C. albicans transition from planktonic to biofilm phase.
Pre-treatment with LCA and DCA reduced C. albicans attachment to HCT116 cells
The effect of LCA and DCA on C. albicans attachment to HCT116 cells was investigated. Candida albicans was pre-treated with ethanol (vehicle), 0.01% LCA, 0.05% DCA or a combination of both for 2 h. HCT116 cells were infected with pre-treated C. albicans for 15 min and the number of C. albicans attached to HCT116 cells was determined by CFU counting and fluorescent staining. To rule out if LCA or DCA pre-treatment has any effect on C. albicans viability, bile acid pre-treated C. albicans was plated onto YPD agar and CFU was determined in control and treatment groups. Results indicate that pre-treatment with LCA or DCA for 2 h has no effect on C. albicans viability (Fig 5A) . However, C. albicans pretreated with bile acids significantly reduced the ability to attach to HCT116 cells. All treatments showed that about 40% reduction in C. albicans attached to the HCT116 cells compared to ethanol pre-treated control cells (Fig. 5B ). Microscopic observations of LCA and DCA pre-treated C. albicans cells attached to HCT116 cells further confirm these findings (Fig. 5C ). Taken together, C. albicans pre-treated with LCA or DCA or combination of LCA and DCA significantly reduced the attachment of C. albicans to HCT116 cells.
DISCUSSION
Bile acids are synthesized in the liver and secreted by the gallbladder to aid in digestion of nutrients and excretion of drugs and other toxins, in addition to playing a critical role in metabolic homeostasis maintenance (Staels and Fonseca 2009; Chiang 2013) . The primary bile acids in humans are cholate (CA) and chenodeoxycholate (CDCA) and the primary bile acids in mice are CDCA and muricholic acid (MCA) (Chiang 2013) . Primary bile acids are secreted into the digestive tract and are either reabsorbed in the terminal ileum or continue transportation into the large intestine, where they are metabolized Candida albicans grown in 96-well plates in the presence or absence of bile acids for 12 h; the supernatant was removed and adherent hyphae growths were stained with crystal violet. Plates were dried and crystal violet was dissolved, and absorbance was measured using a spectrophotometer at 590 nm. Percent hyphal growth in different groups was determined relative to the ethanol-treated control group. (B) Candida albicans treated with bile acids were imaged at ×40 magnification. Experiments were repeated at least three times and representative data are shown here. (C) Candida albicans treated with 0.01% LCA, 0.05% DCA, 0.01% LCA + 0.05% DCA or ethanol (vehicle) and their CFUs were determined. Data are represented as means ± SEM. Statistical significance was evaluated using Student's t-test and P values ( * ≤ 0.05, * * ≤ 0.01) were considered as significant.
by the gut microbiome into secondary bile acids, including LCA, DCA, HDCA and UDCA (Staels and Fonseca 2009; Chiang 2013) . Using a metabolomics approach, Theriot, Bowman and Young (2016) recently determined the in vivo concentrations of bile acids in the murine gut contents and elucidated the role of secondary bile acids in Cl. difficile spore germination and growth in large intestine. Another study by Studer et al. (2016) demonstrated that gut commensal bacteria Cl. scindens-which is best characterized for 7α-dehydroxylation, an important bile transformation process to produce DCA and LCA in the gut-are associated with protection from Cl. difficile infection in a gnotobiotic mouse. These studies indicate that DCA and LCA play an important role in GI colonization resistance against Cl. difficile. GI colonization of C. albicans is a critical predisposing factor for invasive infections (Nucci and Anaissie 2001; Miranda et al. 2009 );therefore, understanding the mechanisms associated with GI colonization is essential for developing novel approaches to prevent C. albicans colonization and pathogenesis. The cecum of the mouse is often used to monitor C. albicans colonization since colonization typically occurs in the cecum (Ekenna and Sherertz 1987; Kennedy et al. 1987; Bendel et al. 2000 Bendel et al. , 2002 Bai, Liu and Tong 2004) . Based on previous studies on Cl. difficile, we hypothesized that secondary bile acids may have direct antifungal activity against C. albicans and may further play a critical role in maintaining GI colonization resistance against C. albicans. Antibiotic treatment associated with loss of GI colonization resistance against C. albicans may stem from altered gut microbiota composition and subsequent changes in secondary bile acid pools, allowing C. albicans growth and morphological switching from commensal yeast to a virulent, pathogenic, hyphal phase, leading to colonization and dissemination (Lo et al. 1997; Felk et al. 2002) . Therefore, understanding the effect of secondary bile acids on C. albicans growth and morphological switching is critical to develop novel microbiome-based therapeutics to prevent C. albicans GI colonization and dissemination.
To elucidate if secondary bile acids exhibit antifungal activity against C. albicans, we conducted in vitro studies to determine if in vivo concentrations of secondary bile acids present in the cecum were able to inhibit C. albicans growth and morphogenesis. A preliminary in vitro study by Marshall et al. (1987) revealed the potential role of selected primary and secondary bile acids (CA, CDCA, DCA, HDCA and LCA) in inhibiting the growth of C. albicans. However, these findings were not based on in vivo bile acid levels in the cecum. More importantly, the effect of secondary bile acids on C. albicans morphologic switching and its ability to attach and invade intestinal cells were not investigated. Defining the effect of secondary bile acids on C. albicans growth and morphogenesis is critical for the development of targeted fungal therapeutics to prevent C. albicans colonization and pathogenesis.
In this study, we found that secondary bile acids, mainly LCA and DCA, at in vivo cecal concentrations effectively inhibit the growth of C. albicans. Although other secondary bile acids including HDCA and UDCA also inhibit C. albicans growth, the antifungal effect was seen only at very high concentrations that were not correlated with in vivo cecal micelle concentration (Theriot, Bowman and Young 2016) . More importantly, LCA and DCA at in vivo cecal micelle concentration had also significant effects on C. albicans (i) germ tube and hyphae formation, and (ii) biofilm formation. These results indicate that LCA and DCA inhibit C. albicans (i) transition from yeast to virulent hyphal form, and (ii) transition from planktonic to biofilm phase. The transition from yeast to hyphal form of C. albicans is not completely understood; however, it is known that C. albicans transitions from an ovoid shape to a filamentous, elongated hyphal form via germ tube formation from the cell that elongates into a filament (Rida et al. 2006) . Inhibition of the morphological plasticity including germ tube and hyphae formation in C. albicans is critical to reduce the pathogenic potential of the organism (Lo et al. 1997) . It has been shown that C. albicans that lack the ability to develop into a filamentous, hyphal form are avirulent (Lo et al. 1997) . Taken together, we found that LCA and DCA have a profound role on C. albicans morphogenesis. Previous studies elucidated the ability of C. albicans hyphae to attach and invade the intestinal cells leading to invasive infections (Gale et al. 1998; Bendel et al. 1999 ). Since we observed that LCA and DCA inhibit germ tube and hyphae formation, we moved forward to investigate if LCA and DCA have any effect on the ability for C. albicans to attach to intestinal cells. Interestingly, results from our study demonstrate that C. albicans pretreated with LCA, DCA and their combination significantly reduced the percentage of C. albicans cells attached to the colon cancer cell line. Morphological switching from yeast to hyphal form plays an important role in C. albicans attachment and subsequent colonization in the gut (Gale et al. 1998; Bendel et al. 1999) . In summary, in vitro results from this study reveal that secondary bile acids play an important role in controlling the growth and morphological switching in C. albicans, and significantly inhibit the ability of Candida cells to attach to intestinal cells. Future therapies to restore colonization resistance against C. albicans could potentially include targeted bacterial cocktails that are able to restore the level of secondary bile acids in the large intestine to inhibit C. albicans growth, morphogenesis and subsequent GI colonization and dissemination. This is the first study to highlight the potential role of LCA and DCA on C. albicans morphogenesis. While the concentrations of secondary bile acids utilized in this study only correlate to the in vivo cecal micelle concentration in mice, our data nevertheless highlight the potential role of DCA and LCA in preventing GI colonization and subsequent pathogenesis of C. albicans. Further investigation in this field necessitates in vivo mice models to dissect the role of secondary bile acids on GI colonization and dissemination of C. albicans. Results from this study also form a strong platform for future studies to explore the use of bacterial cocktails to restore the level of secondary bile acids to prevent C. albicans GI colonization and subsequent pathogenesis in humans, particularly in immunocompromised individuals.
